News Category
The August Wellness Index Report highlights the critical gap between longevity research and real-world patient care, emphasizing the need for translat...
Mitch Gould, founder and CEO of Nutritional Products International, will attend the ECRM session to connect with retailers and showcase his 'Evolution...
Treasury Secretary Bessent's boast of inside information on the yen underscores a shift where policymakers act as market insiders, raising stakes for ...
The WIPO Global Innovation Index 2026 ranks the Shenzhen-Hong Kong-Guangzhou cluster as the world's leading innovation hub, highlighting Hong Kong's s...
Greenland Mines announces a Q4 2026 spin-off of its biotech division and key milestones in its transition to a critical minerals company, including Na...
Nano-X Imaging's new distribution agreement with Associated X-Ray Imaging Corp. aims to broaden access to its FDA-cleared Nanox.ARC system in New Engl...
SS Innovations International is leveraging its established SSi Mantra surgical robotic system in India to drive international expansion, evidenced by ...
VERAXA Biotech's appointment of Raju Willener as CFO signals a strategic move to bolster its financial leadership and advance its proprietary BiTAC te...
Scinai Immunotherapeutics refocuses its R&D portfolio on its NanoAb platform and CDMO business after terminating its license with PinCell, aiming to p...
Onco-Innovations Ltd. strengthens its clinical foundation through manufacturing milestones, IND-enabling activities, and funding, positioning its PNKP...
Wearable Devices will present its AI-powered neural sensing technology at Physical AI 2026, aiming to enhance robotic training with human motor data.
OS Animal Health, a subsidiary of OS Therapies, is spotlighted at the Moody Capital conference for its promising OST-HER2 immunotherapy targeting cani...
Quantum BioPharma's FDA clearance to test Lucid-MS, a first-in-class remyelinating agent, in a Phase 2 trial marks a potential breakthrough in treatin...
Researchers at Washington University School of Medicine have advanced laser interstitial thermal therapy (LITT) as a less invasive brain cancer treatm...
Ocumetics Technology Corp. has initiated patient recruitment for the second group of its human clinical study, moving beyond safety to evaluate the pe...
Quantum BioPharma's FDA clearance to test Lucid-MS, a first-in-class remyelinating agent, in a phase 2 trial could herald a new era in MS therapy, add...
NanoViricides has registered its Phase II trial for NV-387 Oral Gummies against Ebola in the Pan African Clinical Trials Registry, marking a critical ...
Nutriband received a USPTO Notice of Publication for trademarks related to its abuse-deterrent fentanyl patch, moving closer to market entry with pote...
Greenland Mines' plan to spin off its biotech division and its completed acquisition of the Sarfartoq rare earths project underscore its strategic piv...
Quantum BioPharma's FDA clearance for Lucid-MS Phase 2 trial could revolutionize MS therapy by targeting demyelination rather than immunosuppression, ...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS, a first-in-class drug targeting demyelination, could redefine MS therapy by offerin...
American Fusion's expansion of its patent portfolio to 130 applications and its potential uplisting to a national exchange signal significant progress...
The LGL Group’s participation in the Moody Capital conference underscores its strategic focus on critical technologies and disciplined capital allocat...
Interlink Electronics' participation in the Moody Capital conference underscores its strategic growth initiatives and reinforces its position in high-...
As life sciences and AI-driven energy and compute infrastructure see heightened small-cap activity, Moody Capital’s September conference offers a time...
Tonix Pharmaceuticals' promotion of Thomas Englese to Chief Commercial Officer underscores the company's strategic focus on commercializing TONMYA, th...
Synbio International's exclusive licensing agreement with MD PHD Wellness to commercialize proprietary nutraceuticals in the U.S. and Canada accelerat...
AcroMeta Group Limited announced a non-binding term sheet with Macro HRD to acquire a stake in Macro-ATCLS and an option for an exclusive Southeast As...
AOM Capital's $3.8 million bridge loan to a healthcare company highlights the growing niche of receivables-backed financing in the healthcare sector, ...
Nanox Imaging's new distribution agreement with Associated X-Ray Imaging Corp. aims to broaden access to its FDA-cleared 3D tomosynthesis system in Ne...
Precious metals and related ETFs declined sharply as markets adjusted to shifting U.S. monetary policy expectations, impacting miners like New Pacific...
A large study reveals that the timing of brain metastasis development significantly impacts survival in colorectal cancer patients, highlighting the n...
A new report reveals that investors have lost at least $4.7 billion in cryptocurrency projects connected to President Trump, highlighting the volatili...
SS Innovations International reports strong revenue growth and expanding international footprint, positioning its SSi Mantra system for potential regu...
Onco-Innovations has made significant preclinical progress on its PNKP inhibitor ONC010, including high-purity API production and a planned Australian...
VERAXA Biotech's appointment of seasoned financial leader Raju Willener as CFO signals a strategic move to strengthen capital markets expertise and su...
AgeReverse will introduce its longevity supplement RESURGE to retail buyers at the ECRM session, marking a key step in its U.S. expansion and highligh...
A new memoir by Adrian Pelkus offers a personal account of his decades as an inventor and entrepreneur, while also critiquing recent U.S. patent laws ...
ZC Institute announces plans for a fusion reactor prototype that aims to recover lost energy by deflecting neutrons, with independent tests at UAH to ...
BioVersys, a clinical-stage biopharmaceutical company developing novel antibacterials for multi-drug resistant infections, will present at the H.C. Wa...
OS Therapies' participation in the Moody Capital conference comes as the company anticipates key regulatory decisions and data readouts for its lead c...
A Swiss-led preclinical study reveals that administering immunotherapy before surgery significantly improves glioblastoma treatment outcomes, potentia...
Frontieras North America leverages its leaders' expertise in engineering, finance, and industrial operations to navigate the challenging path from dev...
Nightfood Holdings (OTCQB: NGTF), operating as TechForce Robotics, is broadening its AI-powered enterprise automation platform into pharmaceuticals, s...
Greenland Mines' shareholder letter underscores key milestones including Sarfartoq acquisition and Skaergaard resource upgrade, positioning the compan...
Clym Environmental's new Frostburg facility uses innovative ozone technology and solar power to process biohazardous waste, marking a significant step...
The FDA's failure to aggressively enforce laws against the illegal sale of the unapproved drug retatrutide has enabled a dangerous black market, under...
Viromed Medical AG strengthens its Medical Advisory Board with Prof. Dr. Michael A. Rubhausen, a renowned physicist and spectroscopy expert, to enhanc...
